Home › Research › Digital health tools
Identifying natural inhibitors against FUS protein in dementia through machine learning, molecular docking, and dynamics simulation
Darwin Li. Frontiers in Neuroinformatics, 2025-02-05
Topic: Brain proteins, microglia and lab models
Plain-language summary
Dementia, a complex and debilitating spectrum of neurodegenerative diseases, presents a profound challenge in the quest for effective treatments. The FUS protein is well at the center of this problem, as it is frequently dysregulated in the various disorders. We chose a route of computational work that involves targeting natural inhibitors of the FUS protein, offering a novel treatment strategy. We first reviewed the FUS protein's framework; early forecasting models using the AlphaFold2 and SwissModel algorithms indicated a loop-rich protein-a structure component correlating with flexibility. However, these models showed limitations, as reflected by inadequate ERRAT and Verify3D scores. Seeking enhanced accuracy, we turned to the I-TASSER suite, which delivered a refined structural model affirmed by robust validation metrics. With a reliable model in hand, our study utilized machine learning techniques, particularly the Random Forest algorithm, to navigate through a vast dataset of phytochemicals. This led to the identification of nimbinin, dehydroxymethylflazine, and several other compounds as potential FUS inhibitors. Notably, dehydroxymethylflazine and cleroindicin C identified during molecular docking analyses-facilitated by AutoDock Vina-for their high binding affinities and stability in interaction with the FUS protein, as corroborated by extensive molecular dynamics simulations. Originating from medicinal plants, these compounds are not only structurally compatible with the target protein but also adhere to pharmacokinetic profiles suitable for drug development, including optimal molecular weight and LogP values conducive to blood-brain barrier penetration. This computational exploration paves the way for subsequent experimental validation and highlights the potential of these natural compounds as innovative agents in the treatment of dementia.
What this study adds
Evidence grade: Low
This is a computer-based study that used machine learning and molecular simulations to find natural compounds that might bind the FUS protein, which is dysregulated in some dementias. It is early, laboratory-level work and does not show that any of these compounds treat or prevent dementia in people.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Li, D. (2025). Identifying natural inhibitors against FUS protein in dementia through machine learning, molecular docking, and dynamics simulation. Frontiers in Neuroinformatics. https://doi.org/10.3389/fninf.2024.1439090
Vancouver
Li D. Identifying natural inhibitors against FUS protein in dementia through machine learning, molecular docking, and dynamics simulation. Frontiers in Neuroinformatics. 2025. doi:10.3389/fninf.2024.1439090. PMID: 39975842.
BibTeX
@article{li2025-39975842,
author = {Li, Darwin},
title = {{Identifying natural inhibitors against FUS protein in dementia through machine learning, molecular docking, and dynamics simulation}},
journal = {Frontiers in Neuroinformatics},
year = {2025},
doi = {10.3389/fninf.2024.1439090},
pmid = {39975842},
url = {https://doi.org/10.3389/fninf.2024.1439090}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- With a reliable model in hand, our study utilized machine learning techniques, particularly the Random Forest algorithm, to navigate through a vast dataset of phytochemicals.
- This led to the identification of nimbinin, dehydroxymethylflazine, and several other compounds as potential FUS inhibitors.
- Notably, dehydroxymethylflazine and cleroindicin C identified during molecular docking analyses-facilitated by AutoDock Vina-for their high binding affinities and stability in interaction with the FUS protein, as corroborated by extensive molecular dynamics simulations.
- Originating from medicinal plants, these compounds are not only structurally compatible with the target protein but also adhere to pharmacokinetic profiles suitable for drug development, including optimal molecular weight and LogP values conducive to blood-brain barrier penetration.
- This computational exploration paves the way for subsequent experimental validation and highlights the potential of these natural compounds as innovative agents in the treatment of dementia.
Why it matters
This is a computer-based study that used machine learning and molecular simulations to find natural compounds that might bind the FUS protein, which is dysregulated in some dementias. It is early, laboratory-level work and does not show that any of these compounds treat or prevent dementia in people.
New to this subject? Start with our plain-English guide: Digital health →
Study details
- Evidence strengthLow
How this study scored 34/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 33 of the 96 points we could judge it on, which is 34 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Frontiers in Neuroinformatics) |
| Journal's citation record | 1 / 4 | Frontiers in Neuroinformatics: journal h-index 111 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 5 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 2.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 5 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Darwin Li holds only 2 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 0 / 3 | Upper Canada College: institution h-index 12 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39975842) |
| Free to read | 2 / 2 | Free to read |
| Points | 33 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 33 of the 96 points we could judge it on is 34 out of 100. |
| Total | 34 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3389/fninf.2024.1439090
- PubMed: 39975842
- Original source →
- Free full text: Frontiers in Neuroinformatics →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Digital health tools from nearby years
Also tagged “tdp-43”
1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.